HUTCHMED (China) (HMDCF) Gross Margin (2015 - 2021)
HUTCHMED (China) (HMDCF) reported Gross Margin of 83.81% for Q2 2021, up 3482.0% year-over-year from 2.34% in Q2 2020, and down 9.85% quarter-over-quarter from 92.97% in Q1 2021.
HUTCHMED (China) (HMDCF) Gross Margin (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has 6 years of Gross Margin data on file, last reported at 83.81% in Q2 2021.
- Gross Margin for Q2 2021 came in at 83.81%, up 3482.0% year-over-year; the trailing twelve-month figure through Jun 2021 was 89.04% (up 4005.0% YoY), and the FY2025 annual result was 38.68%, down 135.0% from the prior year.
- Gross Margin retreated to 83.81% in Q2 2021 per HMDCF's latest filing, from 92.97% in the prior quarter.
- Over five years, Gross Margin peaked at 120.96% in Q4 2019 and troughed at 48.99% in Q2 2020.
- A 4-year average of 90.44% and a median of 92.45% in 2019 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2020 and 2021: Gross Margin tumbled 4358 bps in 2020, then surged 3482 bps in 2021.
- A 4-year view of Gross Margin shows it stood at 92.32% in 2018, then soared by 31 bps to 120.96% in 2019, then tumbled by 60 bps to 48.99% in 2020, then jumped by 71 bps to 83.81% in 2021.
- Business Quant data shows HMDCF's Gross Margin at 83.81% in Q2 2021, 92.97% in Q1 2021, and 48.99% in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 49.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 71.66% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 82.93% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 49.50% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 98.31% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.26% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -293.83% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 65.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 61.20% |
| 10 | HUTCHMED (China) | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 83.81% |
| Mar 31, 2021 | 92.97% |
| Jun 30, 2020 | 48.99% |
| Mar 31, 2020 | 94.97% |
| Dec 31, 2019 | 120.96% |
| Sep 30, 2019 | 91.57% |
| Jun 30, 2019 | 92.57% |
| Mar 31, 2019 | 92.74% |
| Dec 31, 2018 | 92.32% |
| Sep 30, 2018 | 92.75% |
| Jun 30, 2018 | 90.42% |
| Mar 31, 2018 | 91.18% |
| Jun 30, 2016 | 71.54% |
| Jun 30, 2015 | 59.24% |